How Much Weight Do You Lose Taking Ozempic?

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has become one of the most studied weight-loss medications in recent years, with robust clinical evidence supporting its effectiveness. The drug works by slowing stomach emptying and signaling fullness to the brain, leading to reduced calorie intake. PlexusDx offers compounded semaglutide injections starting at $149/month, allowing patients across all 50 states to access this treatment without insurance or membership fees.

Clinical Trial Weight Loss Data for Semaglutide

Major clinical trials have documented consistent weight reduction outcomes across diverse patient populations. In the STEP 1 trial, participants receiving semaglutide 2.4 mg weekly achieved an average weight loss of 10.5 kg over 68 weeks, compared to just 3.3 kg in the placebo group. This represents approximately 15% total body weight reduction, a threshold considered clinically significant by endocrinologists and bariatric medicine specialists.

Real-world outcomes from compounding pharmacies show that individual results range from 5% to 25% body weight loss depending on starting weight, adherence, and genetic factors. Patients with higher baseline body mass index often experience greater absolute weight loss, though percentage reductions remain proportional. The medication's effects typically become noticeable within 4–6 weeks of consistent dosing.

Factors That Influence Your Personal Weight Loss Results

Your genetic makeup plays a substantial role in how your body responds to semaglutide therapy. PlexusDx's Precision Peptide Genetic Test identifies variations in key pathways—including GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313—that predict how effectively your body will respond to GLP-1 receptor activation. Patients with certain genetic profiles may see faster initial weight loss or require lower maintenance doses.

Lifestyle factors such as dietary quality, physical activity, and sleep duration directly interact with medication efficacy. Patients who reduce processed food intake and engage in moderate exercise often exceed average weight loss expectations by 20–30%. Conversely, inconsistent medication adherence, high-stress periods, and inadequate hydration can slow progress. PlexusDx recommends discussing these modifiable factors with your provider to optimize your personal outcomes.

Dose Adjustments and Weight Loss Progression Over Time

Semaglutide dosing typically begins at 0.25 mg weekly and increases gradually every four weeks, with most patients reaching therapeutic doses between 1.7–2.4 mg weekly. Each dose increase allows your body to adapt while signaling your appetite center more effectively. Weight loss continues to accelerate with each dosing tier, with the most substantial reductions occurring between weeks 12 and 52 of consistent therapy.

PlexusDx ensures that your dose may increase as your treatment progresses, but your price won't—compounded semaglutide injections remain at one flat monthly rate across all commitment tiers. This transparent pricing model removes barriers to dose optimization, allowing your provider to adjust your treatment based on your individual response rather than cost concerns. Patients who complete the full dose titration schedule typically achieve their maximum weight loss potential within 6–12 months.

Comparing Semaglutide to Other GLP-1 Receptor Medications

Semaglutide demonstrates superior weight loss outcomes compared to older weight-loss medications like phentermine, which produces approximately 5–7% body weight reduction. When compared to other GLP-1 agonists like liraglutide, semaglutide's longer half-life (seven days versus one day) enables once-weekly dosing and sustained appetite suppression, translating to better adherence and consistent results. Tirzepatide, a dual GLP-1 and GIP receptor agonist, shows slightly higher weight loss in some trials but carries similar side-effect profiles and higher baseline costs.

PlexusDx compounded semaglutide injections start at $149/month and remain price-stable regardless of dose escalation, making them an accessible entry point for GLP-1 therapy. Patients seeking additional receptor activation may also explore PlexusDx's tirzepatide injection option, which activates an additional GIP pathway for enhanced weight loss in select populations. The choice between these medications should be guided by your genetic profile, medical history, and personal response preferences.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results on semaglutide?

Most patients notice appetite reduction within 3–5 days and measurable weight loss by weeks 2–4 of consistent dosing. Significant weight reduction (5–10% body weight) typically occurs within the first 12 weeks. PlexusDx patients receiving compounded semaglutide injections often report progressive results as their dose increases from the starting tier through therapeutic levels.

Is the weight loss from semaglutide permanent after stopping the medication?

Weight loss achieved on semaglutide remains stable if lifestyle changes are maintained, though some patients regain weight if they return to pre-treatment eating patterns. Clinical data shows that continued adherence to the medication prevents weight regain more effectively than lifestyle modification alone. PlexusDx recommends discussing long-term management goals with your provider to determine whether maintenance therapy aligns with your health objectives.

What does semaglutide cost at PlexusDx, and does price change with dose increases?

PlexusDx compounded semaglutide injections start at $149/month and remain at a flat rate across all three commitment tiers, regardless of your dose level. This means your dose may increase as your treatment progresses, but your price won't. The medication is HSA/FSA eligible and available in all 50 states without insurance requirements or membership fees.

Are there side effects that might slow my weight loss results?

Common side effects like nausea, constipation, or reduced appetite can affect meal quality and nutrient intake in early weeks, potentially slowing initial progress. These effects typically resolve within 2–4 weeks as your body adjusts. Staying hydrated, eating protein-rich foods, and managing dose increases gradually can minimize side effects and maintain steady weight loss momentum.

Can the PlexusDx Precision Peptide Genetic Test predict my weight loss results?

Yes, PlexusDx's genetic test ($99 add-on after your first month) analyzes 14 pathways and 150+ genetic insights, including GLP1R, GIPR, FTO, and MC4R variants that influence your appetite regulation and metabolism. This test helps your provider predict your likely response to semaglutide, estimate realistic weight loss timelines, and identify whether dual-agonist therapy might serve you better. Results guide personalized dosing and medication selection for optimal outcomes.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.